There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Stephen H. Wu, PhD, is a technical fellow in the Pharmaceutical R&D division of Mallinckrodt PharmaceuticalâCovidien Ltd.

Articles

The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.

An Alternative to the USP Disintegration Test for Orally Disintegrating Tablets

The authors consider several common techniques for verifying the accuracy of liquid-handling equipment and offer guidance for finding the appropriate technique for a given instrument.

Comparing Calibration Technologies for Liquid-Handling Quality Assurance

Poonam Kushwaha is a lecturer of pharmacy at Integral University, Lucknow, India.

A. K. Madan is dean of Pharmaceutical Sciences at M. D. University

Extractables and leachables are a growing concern for pharmaceutical manufacturers and regulatory bodies.

Extractables and Leachables: An Overview of Emerging Challenges

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The high-profile case of contaminated heparin from a Chinese supplier has intensified the debate on the effectiveness of FDA's process for inspecting foreign drug-manufacturing facilities. The article examines proposed legislative and regulatory reforms and actions taken by the agency to improve drug-import safety.

The Anatomy of the Changing Supply Chain

Also, Cobra Biomanufacturing to extend collaboration and form joint venture with ViroMed, Epix Pharmaceuticals CEO resigns, more...

Company and People Notes: Sanofi Pasteur to Acquire Acambis, West Appoints Matthew T. Mullarkey As COO, More...

Senator Sherrod Brown sent a letter to Richard T. Clark, president and chief executive officer of Merck (Whitehouse Station, NJ), to ask for information about the company's reliance on global outsourcing for the manufacture of pharmaceutical ingredients and finished products.

Senator Brown Requests Information about Merck's Outsourcing Procedures

Also, Niro changes its name to GEA Process Engineering; Frances K. Heller joins Exelixis as executive vice-president of business development, more...

Company and People Notes: AMRI Opens In Vitro Laboratory in Singapore; Bristol-Myers Squibb Names Quentin Roach Senior Vice-President and Chief Procurement Officer, More ...

Also, Roche to end HIV/AIDS research program, WuXi PharmaTech makes appointments, more...

Company and People Notes: Solvay Pharma Raises Bid for Innogenetics, Catalent Appoints VP of Printed Components, More...

Also, Catalent Pharma Solutions to collaborate with One World Design and Manufacturing Group, Bioheart appoints Howard J. Leonhardt as CEO, more...

Company and People Notes: Fresenius to Acquire APP Pharmaceuticals, Arete Therapeutics Appoints James Sabry President and CEO, More...

The European Pharmacopeia Commission has published the General Information chapter "Potentially Genotoxic Impurities and European Pharmacopoeia Monographs on Substances for Human Use" in the July 2008 edition of PharmEuropa.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes